Clinuvel Pharmaceuticals Limited Company Information
Clinuvel Pharmaceuticals Limited's employee growth, exchange listings and data sources
Key Information
- Name: Clinuvel Pharmaceuticals Limited
- Ticker: UR9A
- Exchange: DB
- Founded: 1999
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: AU$651.306m
- Listing Market Cap: AU$406.453m
- Shares Outstanding: 49.95m
- Website: https://www.clinuvel.com
Location
- Clinuvel Pharmaceuticals Limited
- 535 Bourke Street
- Level 22
- Melbourne
- Victoria
- 3000
- Australia
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| UR9 | DB (Deutsche Boerse AG) | Yes | Ordinary Shares | DE | EUR | Feb 2001 |
| CUV | ASX (Australian Securities Exchange) | Yes | Ordinary Shares | AU | AUD | Feb 2001 |
| CLVL.F | OTCPK (Pink Sheets LLC) | Yes | Ordinary Shares | US | USD | Feb 2001 |
| CUV | CHIA (Chi-X Australia) | Yes | Ordinary Shares | AU | AUD | Feb 2001 |
| CLVL.Y | OTCPK (Pink Sheets LLC) | SPON ADR EA REP 1 ORD NPV | US | USD | May 2004 | |
| UR9A | DB (Deutsche Boerse AG) | SPON ADR EA REP 1 ORD NPV | DE | EUR | May 2004 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/11/24 07:07 |
| End of Day Share Price | 2024/11/22 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.